May
28

Tinker’s HWR = good summer reading

Health Wonk Review welcomes a new host – the Boston – based Tinker Ready hsa this week’s edition up and running with a Jersey theme.
Welcome, Tinker!


May
28

Medicare for all – not so fast

I’ve been asked to do a point-counter point with Jacob Hacker, one of the more vocal supporters of a Medicare-for-All program.
It’s my contention that Hacker overstates the case for Medicare, and in so doing weakens the case for a public plan option. Specifically, he argues that Medicare has lower administrative costs and does a better job holding down medical trend. I disagree.
Medicare has an unfair advantage over private plans: it doesn’t need to maintain reserves, earn profits to attract capital, or pay premium taxes. These result in big dollar ‘savings’ over private plans. It is also important to note that Medicare’s cost structure is dramatically different in other ways.
1.) Medicare has no underwriting or sales expenses or marketing costs. No commissions, either. This saves a lot of admin dollars. This differential would disappear in a health connector-type system, with the playing field leveled by dramatically reducing commercial healthplans’ marketing costs and elimination of their underwriting expense.
2.) Medicare has one-time enrollment and dis-enrollment, and greatly simplified eligibility processes. This cuts their costs, but would not continue under a connector model.
There’s more here.


May
27

Update – RiteAid-FirstScript kerfuffle

I had a chance to speak with the PR folks from RiteAid this morning, who were responding to my request for additional information about RiteAid’s decision to terminate its relationship with work comp PBM FirstScript.
RiteAid is still participating with other work comp PBMs, just not with FirstScript. Sources also indicate that California-based work comp PBM WorkComp Rx has also been terminated by RiteAid for the same reason – processing comp scripts through group health contracts.
As this is a contracting matter, RiteAid will not comment on it publicly, and I won’t characterize my conversation with their corporate PR staff.
However, other internal sources have confirmed that RiteAid has term’ed their relationship with FirstScript. And I’m also hearing that FirstScript has told at least some of their payer customers that they should have their claimants start using other pharmacy chains. FS is obviously doing this in an effort to force RiteAid back into their network; by threatening to pull customers out of stores, FS is trying to hit the big retailer where it hurts most.
Other PBMs are watching very, very closely – as are other retail chains. If RiteAid backs down (which to date it has shown no intention of doing) expect other PBMs to start using group health contracts to process work comp scripts. If they hold firm, and if other chains follow their lead rather than seeking to benefit from RiteAid’s principled position, order will be restored to the market, rule-abiding PBMs will no longer be penalized, and rule-ignoring PBMs will get their comeuppance.
Hang in there, RiteAid. And to the rest of the chains, do the right thing.


May
27

Work comp bill review survey – additional findings

Note – The public version of the First Annual Survey of Workers Compensation Bill Review will be released Friday. If you would like a copy, do NOT comment here, but send an email to infoATHealthStrategyAssocDOTcom.
I’m finishing up the survey report, need a break from analysis and writing – and some of the results are just too interesting to keep to myself till Friday. (I know, I need to get a life)
One of the less-obvious but more-interesting findings is the way the market’s perceptions about bill review firms have shifted of late. The industry has seen a lot of change at a rapid pace, with Mitchell’s acquisition of SmartAdviser, Coventry’s acquisition and ownership of the code for their bill review system, new management at Medata, CS Stars’ announced departure from the business, the purchase of Stratacare, and Ingenix’ troubles with UCR.
All of these events/transactions have influenced respondents’ views of the industry, and certainly of individual vendors within the industry. Some have risen in stature, while others have declined, and the changes aren’t necessarily what one would think.
One of the last questions in the survey asks respondents to rate each firm on a scale of 1-5, with 5 being best/highest. While respondents’ views of the various BR firms tend to lump them in a fairly narrow band, their statements paint a more complex and more nuanced view.
Couple the individual BR firm ratings with the responses to another question “is the bill review industry meeting payers’ needs?” and the picture that emerges is of an industry that is viewed in general as mediocre, focused more on processing speed and throughput than effective medical management (yes, bill review does have a lot to do with med management), and more reactive than innovative.
Among the vendors reviewed there are a couple notable exceptions, and it is important to note these views are general: depending on the payer’s market, technical abilities, business model, and strategic orientation, one or more vendors may be a great fit. The ‘fit determination’ process is key to successful vendor selection, and according to several respondents that had recently gone through the RFP process, requires much more interaction, discussion, and sharing of information on the part of the payer than they had anticipated. Instead of the typical RFI-RFP-finalists selection-onsite presentations-reference checking/offsite visits-battle over pricing and terms-contracting process, to a person these respondents talked about the need to engage much more deeply with potential bill review vendors than they had anticipated. In some cases this was acceptable to management, but in others a more rigid process prevailed, resulting in (in a couple cases) a less than optimal outcome.


May
26

Work comp pharmacy news – RiteAid dropping FirstScript

Retail pharmacy giant RiteAid is no longer accepting work comp claimants administered by PBM FirstScript. RiteAid, which owns almost ten percent of all retail pharmacies in the nation, decided to terminate their relationship with FirstScript due to a dispute over processing of work comp scripts.
Despite reports to the contrary, RiteAid is still working with other work comp PBMs.
FirstScript uses CVS/Caremark’s network of pharmacies;FirstScript was allegedly processing work comp scripts through the CVS/Caremark group health network, thereby getting lower prices than if the scripts had been identified as workers comp. This has long been a bone of contention among PBMs and retail chains alike, as those PBMs that use work comp contracts typically pay significantly more for their drugs than they would pay under group health (or Medicare) contracts. PBMs that play by the rules (only processing comp scripts via their comp contracts) contend that some PBMs do not play by the same rules, a situation that puts the ‘rule-abiding’ PBMs at a distinct disadvantage.
Retail stores charge more for comp scripts because it costs them significantly more to identify the correct payer, establish eligibility, and comply with utilization review edits and processes. That’s entirely reasonable and appropriate.
Price compression in the comp PBM business has driven down margins, and is likely behind this alleged conflict. As PBMs compete for business in what is a rapidly-maturing market, they make price concessions to get new deals. This drive for share has come smack up against the reality that the PBMs’ cost of goods sold is pretty consistent across all PBMs; thus the ones that want to continue to slash price to gain share have to figure out another way to reduce their cost.
RiteAid is still in the business of filling work comp scripts – just not for FirstScript claimants.
The chain continues to work with other workers comp PBMs, including ScripNet, Progressive, Cypress Care/Healthcare Solutions, Express Scripts/MSC, Aetna, Modern Medical, PMSI/Tmesys, Cogent Health, and MyMatrixx.
Of note, FirstScript claims their network includes 61,000 retail pharmacies. This may not have been updated to reflect the RiteAid termination, as it is next to impossible to have that many retail outlets without RiteAid.
Sources indicate other chains are closely monitoring this situation, as they too have been frustrated by PBMs processing work comp scripts under their group health pricing arrangements. Industry watchers (including your author) have been waiting…and waiting…and waiting for the chains to actually do something to stop this practice. Perhaps other chains will follow RiteAid’s lead and force compliance with their contracts.
Their failure to do so has – and continues to – penalize(d) those PBMs and payers that complied with their contracts.
Kudos to RiteAid for stepping up. About time.


May
21

Health plan CEO Compensation

The fine folks at FierceHealthcare have compiled a list of the top ten health plan CEOs ranked by compensation. The links include details on performance, prior year compensation, and a bit of editorial.
Aetna Ron Williams $24,300,112
CIGNA Ed Hanway $12, 236,740
WellPoint Angela Braly $9,844,212
Coventry Dale Wolf (ret) $9,047,469
Centene Michael Neidorff $8,774,483
Amerigroup James Carlson $5,292,546
Humana Michael McCallister $4,764,309
HealthNet Jay Gellert $4,425,355
Universal American Richard Barasch $3,503,702
UnitedHealth Group Steve Hemsley $3,421,042
Some of these top-ten CEOs saw their compensation drop due to declines in their company stock price or other financial issues (CIGNA, Coventry) while others seem to have been unaffected by deteriorating performance (WellPoint, HealthNet) and settlement of lawsuits (Amerigroup.


May
21

Medco’s health reform debate

Last week PBM giant Medco hosted a discussion of health reform that was one of the better events I’ve encountered – better because the conversation was realistic, pointed, and quickly got into the reality of health care reform – it’s about cost.
Participants were David Snow, Medco CEO; Howard Dean, MD, Chan Wheeler of UnitedHealthGroup, and Ben Sasse, assistant professor of public policy at the University of Texas and a former U.S. assistant secretary of Health and Human Services during the Bush Administration.
Snow led off with a backgrounder on past health care reform efforts reaching back about a hundred years (perhaps I exaggerate). The key observation was fear is used by opponents to stop health care reform, to confuse consumers and grind it to a halt. Opponents of specific aspects of reform are focused on preserving and protecting their future, so they scare Americans so they choose to stay with what they have rather than risking the unknown. While this may seem obvious to some, it is important to remember what derailed reform in the past, as we will certainly see the same tactics used by opponents this time – and in fact, already are.
Snow did dwell on tort reform issues, as all big corporate execs do – to their detriment. For every misrepresented story of hot McDonald’s coffee there are dozens of med mal suits that never get filed. Medco has a solid business reputation, and the tort system is one of the few checks we have on companies like Purdue and Cephalon, companies that are in businesses closely related to Medco’s who damage the entire industry by their reprehensible conduct.
But I digress, if only a little. Snow did mention that there is a movement underway to use evidence based medicine as protection against lawsuits – if EBM guidelines are used appropriately then physicians would have some legal protections against med mal litigation.
Snow did a creditable job reviewing the history of past defeats of health care reform, noting the AMA was extremely effective in defeating pretty much every effort (with the notable exception of Medicare). And these guys have been very creative, becoming expert in employing grass roots efforts to stifle reform. Perhaps the most revealing was the AMA’s coffee cup campaign.
The coffee cup campaign was a very well financed effort by the AMA to defeat Medicare. Featuring a recording by none other than Ronald Reagan, the AMA rallied physicians’ wives (back then there were few female physicians) to support the AMA’s lobbying campaign. Snow pointed out, rather pointedly, that the AMA does a great job of not seeing the future; Medicare was anathema to physicians, yet Medicare has been a great boon to most physicians and other providers.
url.jpeg
All panelists (and Snow) acknowledged that cost has not been addressed in any meaningful way in the reform discussions to date. Dean and Wheeler both agreed that their have been no substantive discussions of health cost control. Interestingly, it appeared to my ears that Dean came out against a single payer plan, saying it would not lead to the innovation and improvements that will help deal with cost and quality issues over long term. He forcefully argued for a public plan option, saying “If you don’t have a public plan [in the mix], you shouldn’t bother…”
I’m beginning to think he’s right.
Finally, one of the better lines I’ve heard came from one of the panelists, in referring to physicians, he described some as ‘partialists not specialists’.
A very accurate, and very useful, description.


May
20

We’ve completed the First Annual Workers Comp Bill Review Survey and there are several highlights worthy of mention. (If you’ve requested a copy of the results you will receive it by the end of next week)
Bill review is considered significantly ‘more important’ than other managed care services by survey respondents (TPAs, carriers, managed care firms, and self-insured employers). While this isn’t consistent across all respondents, most are of the opinion that bill review is where the proverbial rubber/road meeting occurs, and if UR or PPO determinations don’t show up in bill review, they are irrelevant.
Which leads to the next finding – most of the more sophisticated respondents are very, very cognizant of – and frustrated by – the difficulties inherent in integrating BR and other medical management systems, platforms, and vendors. There is a sense that not all UR determinations (numbers of visits for PT, hospital stay duration, epidural steroid injections) appear in the final payments, with many unauthorized services actually performed, billed, and paid.
(note – this is consistent with the result of some, but not all, audits of client data performed by HSA)
Respondents decried the lack of understanding of the complexities of bill review, and the commoditization of the service, on the part of senior management and policyholders alike. Their sense is there is little to no appreciation of the difficulties inherent in staying on top of fee schedule and rule changes, increasingly sophisticated provider billing techniques, and impact of bill review on claims costs. Pressed to reduce costs and staff during this soft market, respondents are frustrated by their inability to convince C-level personnel of the relationship between effective (i.e. well-done and not cheap) bill review and ultimate claims costs and combined ratios.
The ratings of bill review vendors and application providers show respondents are quite current and aware of changes at the various suppliers. Vendors that would have been rated poorly as recently as a year ago are viewed more favorably today, with respondents very much open to considering bill review application vendors that would not have made their first cut twelve months ago.
There were notable differences among and between the various bill review vendors and application providers, differences that ‘didn’t appear until well into the implementation phase’. The perception among respondents was that these differences were due in part to a failure on the front end to be very clear and precise about semantics (what, exactly, is a ‘bill’, what is a ‘rule’, what is a ‘duplicate bill’, when does the clock start and end for turn around time, whose responsibility is it to ensure the DRG grouper complies with and is consistent with specific state regs, and on and on). As a result, costs, throughput, efficiency measures, ‘savings’ and other metrics had to be re-adjusted, causing more than a little agita for program managers.
Finally, some bill review applications and vendors were perceived to be better positioned to address likely changes in the overall health care system. Respondents viewed these vendors as more flexible, more adaptable, and more cognizant of the broader systemic issues and their potential impact on workers comp. One knowledgeable respondent noted “some of these vendors are so focused on comp that they aren’t paying attention to current and likely future changes in Medicare physician and hospital reimbursement…and their systems just won’t support some of the likely changes in Medicare-based fee schedules..”


May
19

Silent PPO legislation coming to a state near you

Expect the Texas legislature to pass laws tightly restricting PPOs before the end of the biennial legislative session June 1. According to WorkCompCentral, the Senate is making considerable progress on a compromise bill that will closely follow the NCOIL model.
The NCOIL model act includes strong disclosure requirements, standards for network contract and discount disclosure, penalties for PPO’s failure to disclose clients to providers, allows providers to refuse discounts taken without a contract and provides for enforcement under Texas’ unfair trade practices laws. (see the WorkCompCentral article for details)
This is good news for payers and providers alike.
Silent PPOs have long been a major bone of contention, leading to countless lawsuits and counter suits by payers and providers, tying up claims in seemingly endless litigation. Not only will the bill – if enacted – reduce legal hassles and the cost of same, I’m also hopeful that it will force payers to stop their endless, pointless, counter-productive discount-shopping.
Picking providers base on how much they’ll cut their rate is beyond dumb,for reasons laid out in detail elsewhere on this blog. Beyond that obvious problem is the damage that process dies to the payer-provider relationship. It tells the provider they are merely a vendor, a bill, a cost. It devalues their role entirely, transforming what is often an already-tense relationship into open warfare.
Payers have to treat providers intelligently, seek to understand their situation and motivations, and try to work with them. Sure some providers are crooks and frauds, but treating all of them as such just ensures claims will be contentious, difficult, and more costly.


May
15

Anne Zeiger at Fierce Healthcare was first to market with the news that the American Hospital Association decided it wasn’t really committed to helping reduce health care spending by $2 trillion over ten years. (from Modern Healthcare)
To be fair, the AHA’s boss said “we did not say that we would save this country $2 trillion on our own…” But he also didn’t commit to any measurable savings – at all.
Wow, it seems like just yesterday the pundits and pols were rejoicing in the new, broad commitment to help the nation cut health care costs. Wait, it was just yesterday…
There’s good news here. We’re blowing thru the meaningless promises, the blandishments and feel-good words quickly. That makes it just slightly more likely we’ll get to the hard stuff, where we’ll actually see if there is enough political will to significantly cut costs enough to cover more Americans.
But I still don’t see it happening.